Biopharma | Piper Sandler

$60.0 Million

Inozyme Pharma, Inc.

Confidentially Marketed Follow-On Offering

$75.0 Million

Black Diamond Therapeutics

Confidentially Marketed Follow-On Offering

$85.0 Million

Sagimet Biosciences

Initial Public Offering

$80.0 Million

Turnstone Biologics Inc.

Initial Public Offering

Apr 16 - 17, 2024 | Boston, MA

Boston, MA

Jan 28 - 30, 2024 | Park City, UT

Park City, UT

$67.9 Million

Praxis Precision Medicines

Confidentially Marketed Follow-On Offering

$134.3 Million

Lexicon Pharmaceuticals, Inc.

Confidentially Marketed Follow-On Offering and PIPE Offering

$150.0 Million

Cogent Biosciences

Confidentially Marketed Follow-On Offering

$172.5 Million

Day One Biopharmaceuticals, Inc.

Confidentally Marketed Follow-On Offering